Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Philips has become aware that a component of the mrx processor board may be susceptible to damage from electrostatic discharge (esd). damage to these components can disrupt ecg and spo2 functionality leading to an inability to perform: - demand mode pacing - 12 lead ecg acquisition and analysis - ecg monitoring via leads - pulse oximetry (spo2) the presence of this condition will be displayed on the ready for use (rfu) indicator as a solid red x with periodic audio chirp. defibrillation fixed mode pacing ecg monitoring via pads/paddles and other monitoring functions are not impacted by this issue.